Total Payments
$188,124
2024 Payments
$48,012
Companies
58
Transactions
834
Medicare Patients
1,072
Medicare Billing
$126,913
Payment Breakdown by Category
Other$150,478 (80.0%)
Food & Beverage$17,051 (9.1%)
Consulting$10,700 (5.7%)
Travel$9,895 (5.3%)
Education$1.25 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $117,228 | 75 | 62.3% |
| Honoraria | $33,250 | 21 | 17.7% |
| Food and Beverage | $17,051 | 700 | 9.1% |
| Consulting Fee | $10,700 | 5 | 5.7% |
| Travel and Lodging | $9,895 | 32 | 5.3% |
| Education | $1.25 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $67,129 | 212 | $0 (2024) |
| ABBVIE INC. | $44,765 | 90 | $0 (2024) |
| SK Life Science, Inc. | $35,532 | 83 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $22,347 | 44 | $0 (2021) |
| LivaNova USA, Inc. | $9,559 | 14 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $1,396 | 46 | $0 (2024) |
| Greenwich Biosciences, Inc. | $1,153 | 37 | $0 (2021) |
| GENZYME CORPORATION | $559.78 | 34 | $0 (2021) |
| Eisai Inc. | $546.75 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $516.17 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48,012 | 125 | UCB, Inc. ($23,087) |
| 2023 | $24,611 | 140 | AbbVie Inc. ($13,501) |
| 2022 | $35,516 | 107 | SK Life Science, Inc. ($14,316) |
| 2021 | $26,055 | 110 | SK Life Science, Inc. ($10,859) |
| 2020 | $13,969 | 74 | SK Life Science, Inc. ($9,346) |
| 2019 | $14,869 | 109 | UCB, Inc. ($13,434) |
| 2018 | $14,161 | 95 | Sunovion Pharmaceuticals Inc. ($12,189) |
| 2017 | $10,931 | 74 | Sunovion Pharmaceuticals Inc. ($10,139) |
All Payment Transactions
834 individual payment records from CMS Open Payments — Page 1 of 34
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Neurology | ||||||
| 12/12/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $54.92 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 12/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $4.17 | General |
| Category: Neurology | ||||||
| 12/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Neurology | ||||||
| 12/05/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,455.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $157.50 | General |
| Category: Neurology | ||||||
| 12/05/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Travel and Lodging | Cash or cash equivalent | $47.00 | General |
| Category: Neurology | ||||||
| 12/05/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Neurology | ||||||
| 11/25/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Neurology | ||||||
| 11/25/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $5.69 | General |
| Category: Neurology | ||||||
| 11/18/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Briviact (Drug) | Travel and Lodging | Cash or cash equivalent | $117.82 | General |
| Category: Neurology | ||||||
| 11/09/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $193.86 | General |
| Category: Neurology | ||||||
| 11/08/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | Cash or cash equivalent | $569.00 | General |
| Category: Neurology | ||||||
| 11/08/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | Cash or cash equivalent | $551.97 | General |
| Category: Neurology | ||||||
| 11/08/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Travel and Lodging | In-kind items and services | $232.83 | General |
| Category: Neurology | ||||||
| 11/08/2024 | LivaNova USA, Inc. | VNS Therapy (Device) | Food and Beverage | In-kind items and services | $214.24 | General |
| Category: Neurology | ||||||
| 11/01/2024 | Medtronic, Inc. | PERCEPT PC BRAINSENSE (Device) | Food and Beverage | In-kind items and services | $66.50 | General |
| Category: Deep Brain Neurostimulation | ||||||
| 10/31/2024 | UCB, Inc. | Fintepla (Drug) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: Neurology | ||||||
| 10/23/2024 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: NEUROLOGY | ||||||
| 10/22/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Neurology | ||||||
| 10/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/08/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Neurology | ||||||
| 10/08/2024 | UCB, Inc. | Briviact (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 246 | 321 | $100,002 | $27,580 |
| 2022 | 11 | 313 | 431 | $131,480 | $35,999 |
| 2021 | 9 | 267 | 386 | $105,534 | $30,876 |
| 2020 | 10 | 246 | 376 | $107,484 | $32,458 |
Total Patients
1,072
Total Services
1,514
Medicare Billing
$126,913
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 51 | 92 | $49,864 | $14,267 | 28.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 78 | 110 | $26,740 | $7,209 | 27.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 55 | 56 | $9,576 | $2,384 | 24.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 24 | 24 | $7,872 | $2,085 | 26.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 23 | 23 | $3,358 | $979.11 | 29.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 16 | $2,592 | $656.11 | 25.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 39 | 79 | $42,818 | $12,511 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 87 | 108 | $26,052 | $7,124 | 27.3% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 15 | 47 | $19,112 | $3,774 | 19.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 53 | $9,487 | $2,893 | 30.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 20 | 20 | $6,560 | $1,984 | 30.2% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 45 | 45 | $7,695 | $1,882 | 24.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 18 | 18 | $6,066 | $1,865 | 30.7% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 13 | 14 | $5,068 | $1,441 | 28.4% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2022 | 16 | 16 | $3,648 | $1,062 | 29.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 13 | 14 | $2,492 | $763.12 | 30.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 17 | 17 | $2,482 | $700.26 | 28.2% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 36 | 66 | $35,772 | $10,554 | 29.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 87 | 140 | $30,600 | $9,676 | 31.6% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 57 | 58 | $9,918 | $2,600 | 26.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 15 | 39 | $6,981 | $2,165 | 31.0% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Facility | 2021 | 12 | 21 | $8,083 | $1,945 | 24.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $4,381 | $1,365 | 31.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 15 | 15 | $4,839 | $1,048 | 21.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 20 | $2,916 | $944.48 | 32.4% |
About Dr. Komal Ashraf, D.O
Dr. Komal Ashraf, D.O is a Neurology healthcare provider based in Columbia, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1457580490.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Komal Ashraf, D.O has received a total of $188,124 in payments from pharmaceutical and medical device companies, with $48,012 received in 2024. These payments were reported across 834 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($117,228).
As a Medicare-enrolled provider, Ashraf has provided services to 1,072 Medicare beneficiaries, totaling 1,514 services with total Medicare billing of $126,913. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Epilepsy
- Location Columbia, MO
- Active Since 07/13/2009
- Last Updated 07/10/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1457580490
Products in Payments
- Briviact (Drug) $53,164
- XCOPRI (Drug) $24,792
- QULIPTA (Drug) $23,777
- APTIOM (Drug) $22,390
- UBRELVY (Drug) $16,741
- Cenobamate (Drug) $9,275
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) $7,797
- Fintepla (Drug) $4,277
- BOTOX (Biological) $4,253
- Nayzilam (Drug) $4,060
- VNS Therapy (Device) $1,762
- EPIDIOLEX (Drug) $1,307
- Epidiolex (Drug) $1,153
- NUEDEXTA (Drug) $476.01
- Fycompa (Drug) $426.09
- KESIMPTA (Drug) $413.19
- AUBAGIO (Drug) $348.51
- PERCEPT PC BRAINSENSE (Device) $318.07
- NURTEC ODT (Drug) $263.77
- TYSABRI (Biological) $193.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Columbia
Robert Burger, M.d, M.D
Neurology — Payments: $161,599
Neurology $161,599
Davit Mrelashvili, Md, MD
Neurology — Payments: $75,856
Neurology $75,856
Louise Ledbetter, Md, MD
Neurology — Payments: $59,320
Neurology $59,320
Dr. Sudhir Batchu, Md, MD
Neurology — Payments: $47,310
Neurology $47,310
Pradeep Bollu, Md, MD
Neurology — Payments: $43,976
Neurology $43,976
Dr. Eleanya Ogburu-Ogbonnaya, M.d, M.D
Neurology — Payments: $40,320
Neurology $40,320